Clinical trial Recruiting at 2 sites Observational Ages 18 and up

When and how much fluid to remove in critically ill patients

Official title: Timing and Dose of Fluid Deresuscitation in Critically Ill Patients: a Prospective Observational Multicenter Study

Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT07275658 · Data updated 2026-11-12

This study will test which patients, timing, and rates of fluid removal (diuretics or ultrafiltration) work best for critically ill adults in the ICU who need deresuscitation.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academic / other
Locations2 sites (Amsterdam and 1 other locations)
StatusRecruiting
StartedOctober 15, 2025
Main results expectedJanuary 31, 2027
Study endsFebruary 28, 2027
Registry record updatedJanuary 21, 2026
Trial IDNCT07275658 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult ICU patients at a participating site who have a first clinical indication for deresuscitation using diuretics or ultrafiltration as decided by the treating physician are ideal candidates.

Probably not a fit

Patients under 18, those with major cardiac shunts or moderate-to-severe aortic regurgitation, morbid obesity (BMI >40), pre-existing lung disease preventing reliable ultrasound, those on ECMO or transferred from another ICU, moribund patients, or those who opt out are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, prospective observational cohort of adult ICU patients who have a treating-physician–determined indication for deresuscitation. Clinical data, point-of-care ultrasound measures, and laboratory and metabolic profiles will be collected during the first attempt at deresuscitation. The primary outcome is successful deresuscitation, defined as achieving a negative fluid balance within 24 hours without hemodynamic consequences, with secondary work on timing, rate (dose) and subgroup differences (sepsis, ARDS, cardiac patients). Analyses will explore predictors of diuretic and ultrafiltration response, optimal individualized deresuscitation rates, and associations with complications such as electrolyte/acid–base disturbances, hemodynamic instability, atrial fibrillation, and delirium.

Why it matters

Potential benefit: If successful, the findings could help clinicians personalize when and how fast to remove fluid to make deresuscitation safer and more effective, potentially reducing complications.

How similar studies have gone: Previous research supports conservative fluid management and diuresis in critical illness, but prospectively defining determinants and individualizing timing and dose using integrated ultrasound and metabolic profiling is relatively novel and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Admission to one of the participating ICUs;
* Clinical indication for deresuscitation using diuretics or ultrafiltration as set by the treating physician; first attempt during the ICU stay.

Exclusion Criteria:

* Age below 18 years old;
* Major cardiac shunts;
* Moderate to severe aortic regurgitation;
* Morbid Obesisty (BMI \>40);
* POCUS impossible or unreliable (i.e. pre-existing interstitial lung disease);
* PLR or modified form of PLR impossible (i.e. ECMO);
* Transfer from another ICU;
* Previous inclusion in this study;
* Patients who are moribund or facing the end of life;
* Opt out.

Where it's running

  • Olvg
    Amsterdam, Netherlands
    Recruiting
  • Amsterdam UMC
    Amsterdam, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.